Workflow
Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates
Daré BioscienceDaré Bioscience(US:DARE) ZACKS·2025-08-15 06:15

Dare Bioscience, Inc. (DARE) came out with a quarterly loss of 0.45pershareversustheZacksConsensusEstimateofalossof0.45 per share versus the Zacks Consensus Estimate of a loss of 0.55. This compares to earnings of 1.52pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof+18.181.52 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.18%. A quarter ago, it was expected that this company would post a loss of 0.63 per share when it actually produced a loss of $0.5, delivering a surprise of +20.63%.Over the last four quarters, the company h ...